ABSTRACT
BACKGROUND: Breast cancer is the most deadly malignancy in Mexican women. Although treatment has improved, it may significantly affect bone mineral status in those who receive it. The aim of this study was to assess the impact of cancer treatment on bone mineral density (BMD) and bone mineral content (BMC), in patients with breast cancer and explore the interaction of menopausal status and clinical stage with cancer treatment on such changes. METHODS: A quasi-experimental design was applied with measurements before and after a chemotherapy treatment in 40 patients with primary diagnosis of invasive breast cancer. BMD and body composition measurements were taken by dual X-ray absorptiometry (DXA) and changes in these variables due to therapy were analyzed using mixed regression for repeated measurements. RESULTS: Significant loss was found in femoral neck and L2-L4 BMD (p < 0.001). Patients diagnosed with osteopenia or osteoporosis received calcium + vitamin D supplementation (600 mg/200 IU day). It showed a protective effect in the decrease of femoral neck BMD and total BMC. BMD loss in both femoral neck and L2-L4 BMD was higher in premenopausal women: 0.023 g/cm2 in femoral neck and 0.063 g/cm2 in L2-L4 (p < 0.001), while in postmenopausal women BMD loss was 0.015 g/cm2 in femoral neck and 0.035 g/cm2 in L2-L4 (p = 0.021 and p = 0.001 respectively). Change in lumbar spine BMD was prominent in premenopausal women with advanced clinical stage (IIB, IIIA, IIIB): 0.066 g/cm2 (p = 0.003). CONCLUSION: The antineoplastic breast cancer treatment with chemotherapy had a negative impact on BMD, in premenopausal women overall, although a differential effect was found according to clinical stage and calcium supplementation status.
Subject(s)
Antineoplastic Agents/adverse effects , Bone Density , Bone Diseases/etiology , Bone Diseases/pathology , Breast Neoplasms/complications , Adult , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biomarkers, Tumor , Breast Neoplasms/diagnosis , Breast Neoplasms/drug therapy , Breast Neoplasms/metabolism , Female , Humans , Menopause , Mexico , Middle Aged , Neoplasm Staging , Risk FactorsABSTRACT
BACKGROUND: Breast cancer is the most commonly diagnosed malignancy in women in Mexico and also has the highest mortality. Although treatment has improved significantly, it can affect the nutritional status of the recipients. OBJECTIVE: The aim of this study was to assess the impact of the initial phase of antineoplastic therapy on the nutritional status in patients with breast cancer. METHODS: Forty subjects with primary diagnosed of invasive breast cancer were studied in a before and after intervention (six month apart) using a quasi-experimental design. Basal and six month after intervention measurements included were anthropometry, body composition by dual X-ray absorptiometry (DEXA), diet by 24-hour recall and food frequency questionnaire, as well as serum ï¢-carotene and retinol. The therapy effect was analyzed using repeated measurements mixed linear regression. RESULTS: Lean tissue decreased after the studied period (p=0.032). Addicionally, there was an interaction between weight, BMI and body fat parameters with menopausal status, increasing in these variables due to therapy only premenopausal patients (p=0.005, 0.006 and 0.001, respectively). Decreased serum retinol (p=0.049) despite the improvement in ï¢-carotene status (p=0.03). In general there was an increase the consumption of vegetables food products whilst a decrease in animal foods. CONCLUSION: The breast cancer antineoplastic treatment had a negative effect on weight and body fat, especially in young women. Although there were some positive dietary changes, vegetables consumption remained insufficient, which was also reflected in serum biomarkers.
Presentación: El cáncer de mama es el tipo de tumor más frecuentemente diagnosticado entre las mujeres de México y también el de más alta mortalidad. Aunque el tratamiento ha mejorado significativamente, puede afectar al estado nutricional del paciente. Objetivo: El objetivo de este estudio era evaluar el impacto de la fase inicial de la terapia antineoplásica sobre el estado nutricional en pacientes con cáncer de mama. Métodos: Cuarenta sujetos con diagnóstico primario de cáncer de mama invasivo fueron estudiados antes y después de la intervención (con seis meses de desfase) usando un diseño quasi-experimental. Las mediciones al inicio y seis meses después de la intervención incluyeron antropometría, composición corporal mediante absorciometría dual de rayos X (DEXA), cuestionario de recopilación de dieta en 24 horas y frecuencia de comidas, y suero beta-caroteno y retinol. El efecto de la terapia fue analizado empleando mediciones repetidas y regresión lineal mixta. Resultados: El tejido magro disminuyó tras el periodo de estudio (p=0.032). Además, se dio una interacción entre los parámetros de peso, IMC y grasa corporal con el estado de menopausia, aumentando en estas variables debido a la terapia solo en pacientes premenopáusicas (p=0.005, 0.006 y 0.001, respectivamente). Descenso de retinol sérico (p=0.049) a pesar de la mejoría en el estado de beta-caroteno (p=0.03). En general hubo un aumento en el consumo de verdura y un descenso de productos animales. Conclusión: El tratamiento antineoplásico del cáncer de mama tuvo un efecto negativo sobre el peso y la grasa corporal, especialmente en mujeres jóvenes. Aunque se observaron algunos cambios positivos en la dieta, el consumo de verdura siguió siendo insuficiente, lo que también se reflejó en los biomarcadores séricos.
Subject(s)
Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/physiopathology , Nutritional Status/drug effects , Adult , Female , Humans , Middle Aged , Time FactorsABSTRACT
Introducción: El cáncer de mama es la neoplasia más diagnosticada en mujeres en México y también la de mayor mortalidad. Aunque el tratamiento ha mejorado, puede afectar de forma importante el estado nutricio de quienes lo reciben. Objetivo: Evaluar el impacto del tratamiento antineoplásico sobre el estado nutricio en pacientes con cáncer de mama. Pacientes y métodos: Se aplicó un diseño cuasiexperimental, antes y después de seis meses del inicio del tratamiento quimioterapéutico. Participaron 40 pacientes con diagnóstico primario de cáncer de mama invasivo. Se tomaron medidas antropométricas, de composición corporal mediante absorciometría dual de rayos X (DEXA) así como análisis de la dieta mediante recordatorio de 24 horas y cuestionario de frecuencia de consumo. Además, se cuantificaron los biomarcadores séricos, retinol y Beta-caroteno. El efecto del tratamiento se estimó utilizando regresión linear mixta para mediciones repetidas. Resultados: Se registró una pérdida de tejido magro (p=0.03). Además se encontró interacción del climaterio sobre los parámetros de peso, IMC y grasa corporal; solo en las pacientes preclimatéricas aumentaron estas medidas (p=0.005, 0.006 y 0.001 respectivamente). El retinol sérico disminuyó (p=0.049) pese al incremento en el Beta-caroteno (p=0.030). También se incrementó el consumo de vegetales y hubo una reducción en el consumo de alimentos de origen animal. Conclusión: El tratamiento antineoplásico para cáncer de mama afectó negativamente al peso y grasa corporal, principalmente en las mujeres jóvenes. Pese a las modificaciones dietarias, el consumo promedio de vegetales aún es insuficiente, lo cual se reflejó también en los biomarcadores séricos (AU)
Background: Breast cancer is the most commonly diagnosis malignancy in women in Mexico and also has the highest mortality. Although treatment has improved significantly, it can affect the nutritional status of the recipients. Objective: The aim of this study was to assess the impact of the initial phase of antineoplastic therapy on the nutritional status in patients with breast cancer. Methods: Forty subjects with primary diagnosed of invasive breast cancer were study in a before and after intervention (six months apart) using a quasi-experimental design. Basal and six month after intervention measurements included were anthropometry, body composition by dual X-ray absorptiometry (DEXA), diet by 24-hour recall and food frequency questionnaire, as well as serum Beta-carotene and retinol. The therapy effect was analyzed using repeated measurements mixed linear regression. Results: Lean tissue decreased after the studied period (p=0.032).Addicionally, there was an interaction between weight, BMI and body fat parameters with menopausal status, increasing in these variables due to therapy only premenopausal patients (p=0.005, 0.006 and 0.001, respectively). Serum retinol decreased (p=0.049) despite the improvement in Beta-carotene status (p=0.03). In general there was an increase the consumption of vegetables food products whilst a decrease in animal foods products. Conclusion: The breast cancer antineoplasic treatment had a negative effect on weight and body fat, especially in young women. Although there were some positive dietary changes, vegetables consumption remained insufficient, which was also reflected in serum biomarkers (AU)
